Trial intelligence / Profile preview

Testosterone Undecanoate in Simulated Operational Stress (OPS II)

NCT04120363Phase 4Completed

Sponsor
Pennington Biomedical Research Center
Start
Sep 2019
Primary completion
Jul 2021
Modality
Hormone, Biologic
Countries
1
01

Overview

Phase 4, randomised, double-blind trial comparing Testosterone Undecanoate with Placebo (2 arms). Primary endpoints: Load Carriage Time at Day 47, Vertical Jump Height at Day 46 and 3 more. Started Sep 2019; status: completed.

02

Drugs

testosterone undecanoate

Beyond the preview

Go deeper on NCT04120363.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04120363.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call